Heron Therapeutics (HRTX) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Heron Therapeutics Revenue Highlights


Latest Revenue (Y)

$127.04M

Latest Revenue (Q)

$46.54M

Main Segment (Y)

C I N V A N T I

Heron Therapeutics Revenue by Period


Heron Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$127.04M17.99%
2022-12-31$107.67M24.70%
2021-12-31$86.35M-2.59%
2020-12-31$88.64M-39.28%
2019-12-31$145.97M88.41%
2018-12-31$77.47M151.81%
2017-12-31$30.77M2305.55%
2016-12-31$1.28M100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31--100.00%
2011-12-31$646.00K-50.35%
2010-12-31$1.30M3.17%
2009-12-31$1.26M241.73%
2008-12-31$369.00K-10.44%
2007-12-31$412.00K100.00%
2006-12-31--100.00%
2005-12-31$5.39M-0.24%
2004-12-31$5.40M11.47%
2003-12-31$4.85M-16.63%
2002-12-31$5.82M32.54%
2001-12-31$4.39M30.35%
2000-12-31$3.37M-83.50%
1999-12-31$20.40M2.00%
1998-12-31$20.00M9.29%
1997-12-31$18.30M-2.14%
1996-12-31$18.70M16.15%
1995-12-31$16.10M1.26%
1994-12-31$15.90M-20.10%
1993-12-31$19.90M-

Heron Therapeutics generated $127.04M in revenue during NA 2023, up 17.99% compared to the previous quarter, and up 163.98% compared to the same period a year ago.

Heron Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30$46.54M34.24%
2024-03-31$34.67M1.28%
2023-12-31$34.23M8.90%
2023-09-30$31.43M-1.03%
2023-06-30$31.76M7.25%
2023-03-31$29.61M-1.38%
2022-12-31$30.03M13.07%
2022-09-30$26.56M-3.88%
2022-06-30$27.63M17.79%
2022-03-31$23.46M13.57%
2021-12-31$20.66M-11.08%
2021-09-30$23.23M3.51%
2021-06-30$22.44M12.11%
2021-03-31$20.02M-2.85%
2020-12-31$20.61M3.21%
2020-09-30$19.96M-11.92%
2020-06-30$22.67M-10.76%
2020-03-31$25.40M-27.60%
2019-12-31$35.08M-17.69%
2019-09-30$42.62M16.27%
2019-06-30$36.66M16.00%
2019-03-31$31.60M9.56%
2018-12-31$28.84M45.78%
2018-09-30$19.79M14.52%
2018-06-30$17.28M49.36%
2018-03-31$11.57M15.06%
2017-12-31$10.05M17.28%
2017-09-30$8.57M0.73%
2017-06-30$8.51M134.31%
2017-03-31$3.63M183.97%
2016-12-31$1.28M93.49%
2016-09-30$661.00K100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30--100.00%
2011-06-30$251.00K-36.46%
2011-03-31$395.00K120.67%
2010-12-31$179.00K-49.00%
2010-09-30$351.00K-33.77%
2010-06-30$530.00K119.92%
2010-03-31$241.00K97.54%
2009-12-31$122.00K-89.08%
2009-09-30$1.12M7878.57%
2009-06-30$14.00K75.00%
2009-03-31$8.00K-61.90%
2008-12-31$21.00K-67.19%
2008-09-30$64.00K-57.89%
2008-06-30$152.00K14.29%
2008-03-31$133.00K0.76%
2007-12-31$132.00K-

Heron Therapeutics generated $46.54M in revenue during Q2 2024, up 34.24% compared to the previous quarter, and up 157.16% compared to the same period a year ago.

Heron Therapeutics Revenue Breakdown


Heron Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Z Y N R E L E F$17.73M$10.20M$2.92M--
S U S T O L$13.06M$10.23M$9.91M$800.00K$13.80M
C I N V A N T I$94.87M$87.25M$73.51M$87.80M$132.20M

Heron Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: C I N V A N T I (75.50%), Z Y N R E L E F (14.11%), and S U S T O L (10.39%).

Quarterly Revenue by Product

Product/ServiceMar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Z Y N R E L E F$5.01M$10.07M$4.13M$3.53M$3.90M$2.72M$2.52M$1.10M$824.00K$2.10M--------
C I N V A N T I$25.62M$47.54M$24.47M$22.86M$23.07M$21.17M$22.66M$20.30M$17.31M$18.00M$19.70M$18.50M$20.20M$19.80M$22.60M$25.20M$34.60M$36.40M
S U S T O L$3.62M$7.24M$2.84M$2.98M$3.05M$2.67M$2.45M$2.10M$2.52M$3.10M$2.70M$1.50M$400.00K$200.00K$100.00K$200.00K$500.00K$6.20M

Heron Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: C I N V A N T I (74.81%), Z Y N R E L E F (14.64%), and S U S T O L (10.56%).

Heron Therapeutics Revenue Breakdown by Country

Quarterly Revenue by Country

CountryMar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Z Y N R E L E F$3.53M$3.90M$2.72M$2.52M$1.10M$824.00K$2.10M--------
C I N V A N T I$22.86M$23.07M$21.17M$22.66M$20.30M$17.31M$18.00M$19.70M$18.50M$20.20M$19.80M$22.60M$25.20M$34.60M$36.40M
S U S T O L$2.98M$3.05M$2.67M$2.45M$2.10M$2.52M$3.10M$2.70M$1.50M$400.00K$200.00K$100.00K$200.00K$500.00K$6.20M

Heron Therapeutics's latest quarterly revenue breakdown by geography, as of Mar 23: C I N V A N T I (77.81%), Z Y N R E L E F (12.03%), and S U S T O L (10.16%).

Heron Therapeutics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
HRTXHeron Therapeutics$127.04M$46.54M
HOOKHOOKIPA Pharma$20.13M-
MREOMereo BioPharma Group$10.00M-
XFORX4 Pharmaceuticals-$563.00K
PDSBPDS Bio--
DAWNDay One Biopharmaceuticals-$20.07M
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
TERNTerns Pharmaceuticals--
ELDNEledon Pharmaceuticals--

HRTX Revenue FAQ


Heron Therapeutics's yearly revenue for 2023 was $127.04M, representing an increase of 17.99% compared to 2022. The company's yearly revenue for 2022 was $107.67M, representing an increase of 24.70% compared to 2021. HRTX's yearly revenue for 2021 was $86.35M, representing a decrease of -2.59% compared to 2020.

Heron Therapeutics's quarterly revenue for Q2 2024 was $46.54M, a 34.24% increase from the previous quarter (Q1 2024), and a 46.53% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $34.67M, a 1.28% increase from the previous quarter (Q4 2023), and a 17.07% increase year-over-year (Q1 2023). HRTX's quarterly revenue for Q4 2023 was $34.23M, a 8.90% increase from the previous quarter (Q3 2023), and a 14.00% increase year-over-year (Q4 2022).

Heron Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 47.13%, and for the last 5 years (2019-2023) was -12.96%.

Heron Therapeutics's revenue streams in c 23 are Z Y N R E L E F, S U S T O L, and C I N V A N T I. Z Y N R E L E F generated $17.73M in revenue, accounting 14.11% of the company's total revenue, up 73.86% year-over-year. S U S T O L generated $13.06M in revenue, accounting 10.39% of the company's total revenue, up 27.62% year-over-year. C I N V A N T I generated $94.87M in revenue, accounting 75.50% of the company's total revenue, up 8.74% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of Heron Therapeutics was C I N V A N T I. This segment made a revenue of $94.87M, representing 75.50% of the company's total revenue.